Raymond James Financial’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Raymond James Financial's ABBV Position: Q3 2026 in Review
Raymond James Financial reduced its AbbVie (ABBV) stake by 4.8% in Q3 2026, selling an estimated $129M and leaving 9,906,657 shares worth $2.59B. The position accounts for 0.69% of the portfolio, ranked #19.
Raymond James Financial first reported a position in ABBV in Q4 2024 and has held it in 8 quarters since. The position peaked at $2.62B in Q2 2026. 3,830 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Raymond James Financial held 9,906,657 shares of AbbVie worth $2.59B as of Q3 2026.
- Raymond James Financial sold 503,502 AbbVie shares in Q3 2026, an estimated $129M.
- AbbVie made up 0.69% of Raymond James Financial's portfolio in Q3 2026, its #19 holding.
- Raymond James Financial first reported a position in AbbVie in Q4 2024 and has held it in 8 quarters since.
- Raymond James Financial's AbbVie position peaked at $2.62B in Q2 2026.
- 3,830 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Raymond James Financial's 13F filing for Q3 2026, filed 12 Nov 2026.